To be specific, in the early stages of BRDC, the integrative multi‐omics analysis revealed that sterol hormone receptors (ESR1, NR3C1, and AR) were involved in the BRDC progression from DH to DCIS step by step (Figure S8C, Supporting Information). Here, AR is linked to ductal breast carcinoma in situ.